Indeed, cancer cells hijack the PI3K/Akt/mTOR pathway to promote the induction of survival signals, inhibit apoptotic or cell death signals and acquisition of chemoresistant phenotypes [79,80]. This evidence concerns the gene MTOR and cancer.